# Drug Monitoring of Sorafenib in Patients With Advanced Hepatocellular Carcinoma

> **NCT01078311** · — · UNKNOWN · sponsor: **South West Sydney Local Health District** · enrollment: 100 (estimated)

## Conditions studied

- Hepatocellular Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01078311
- **Lead sponsor:** South West Sydney Local Health District
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-02
- **Primary completion:** 2012-02
- **Final completion:** 2014-02
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2010-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01078311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01078311, "Drug Monitoring of Sorafenib in Patients With Advanced Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01078311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*